Abstract #3318
A comparison of iopromide and iopamidol, two acidoCEST MRI contrast agents that measure tumor extracellular pH
Brianna F. Moon 1 , Liu Qi Chen 2 , Peilu Liu 2 , Christine M. Howison 1 , Kyle M. Jones 1 , and Mark D. Pagel 1,2
1
Department of Biomedical Engineering,
University of Arizona, Tucson, Arizona, United States,
2
Department
of Chemistry & Biochemistry, University of Arizona,
Tucson, Arizona, United States
AcidoCEST MRI contrast agents (CA) iopromide
(UltravistTM, Bayer Health Care, Inc.) and iopamidol
(IsovueTM, Bracco Imaging, Inc.) show similar imaging
characteristics with respect to excitation pulse, method
of frequency encoding, and effects CA concentration, T1
time , and temperature. Iopromide shows better CEST
dynamic range for measuring pH, while iopamidol shows
better precision. Both contrast agents can be used to
measure extracellular pH in vivo.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
